CAMZYOS

bristol-myers squibb canada🇨🇦 Health Canada

Approval Id: 1276fdb8305d7aac
Drug Approval Canada Name: CAMZYOS
Product Name: CAMZYOS
Status: Marketed
Status Date: 2023-08-08
Original Market Date: 2023-08-08
Din: 02532573
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:04.92
Atc Original: C01EB24 MAVACAMTEN
Atc Name: c 01 eb 24
Aig Number: 0164242004
Company Name: bristol-myers squibb canada
Company Address: 2344 Boul. Alfred-Nobel, Suite 300, St-Laurent, Quebec, Canada, H4S 0A4

MAVACAMTEN

15 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1276fdb8305d7aac

Type

Standard